Huang and colleagues found that CASC2 (Cancer Susceptibility 2) was overexpressed in osteoarthritis patients and it could regulate IL17 expression and contribute to chondrocyte proliferation and apoptosis 23. Here, IL17A is linked to osteoarthritis.